Trade Nanostrg Te - NSTG CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.05 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026235% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.004012% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
NanoString Technologies Inc ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Prev. Close* | 0.48 |
Open* | 0.48 |
1-Year Change* | -9.43% |
Day's Range* | 0.48 - 0.53 |
52 wk Range | 0.47-13.20 |
Average Volume (10 days) | 3.90M |
Average Volume (3 months) | 40.63M |
Market Cap | 24.04M |
P/E Ratio | -100.00K |
Shares Outstanding | 48.12M |
Revenue | 162.47M |
EPS | -3.53 |
Dividend (Yield %) | N/A |
Beta | 1.36 |
Next Earnings Date | Feb 26, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Dec 1, 2023 | 0.53 | 0.06 | 12.77% | 0.47 | 0.53 | 0.47 |
Nov 30, 2023 | 0.48 | -0.02 | -4.00% | 0.50 | 0.50 | 0.47 |
Nov 29, 2023 | 0.48 | -0.05 | -9.43% | 0.53 | 0.55 | 0.48 |
Nov 28, 2023 | 0.52 | -0.01 | -1.89% | 0.53 | 0.55 | 0.51 |
Nov 27, 2023 | 0.53 | -0.01 | -1.85% | 0.54 | 0.56 | 0.51 |
Nov 24, 2023 | 0.56 | 0.05 | 9.80% | 0.51 | 0.57 | 0.51 |
Nov 22, 2023 | 0.51 | 0.02 | 4.08% | 0.49 | 0.53 | 0.48 |
Nov 21, 2023 | 0.48 | -0.13 | -21.31% | 0.61 | 0.62 | 0.45 |
Nov 20, 2023 | 0.61 | -0.07 | -10.29% | 0.68 | 0.71 | 0.59 |
Nov 17, 2023 | 1.26 | -0.05 | -3.82% | 1.31 | 1.38 | 1.21 |
Nov 16, 2023 | 1.31 | 0.05 | 3.97% | 1.26 | 1.32 | 1.26 |
Nov 15, 2023 | 1.30 | 0.07 | 5.69% | 1.23 | 1.31 | 1.23 |
Nov 14, 2023 | 1.21 | 0.08 | 7.08% | 1.13 | 1.25 | 1.12 |
Nov 13, 2023 | 1.07 | 0.00 | 0.00% | 1.07 | 1.08 | 1.00 |
Nov 10, 2023 | 1.06 | -0.12 | -10.17% | 1.18 | 1.18 | 1.06 |
Nov 9, 2023 | 1.17 | -0.11 | -8.59% | 1.28 | 1.31 | 1.14 |
Nov 8, 2023 | 1.26 | -0.13 | -9.35% | 1.39 | 1.39 | 1.25 |
Nov 7, 2023 | 1.38 | -0.01 | -0.72% | 1.39 | 1.46 | 1.23 |
Nov 6, 2023 | 1.34 | -0.22 | -14.10% | 1.56 | 1.56 | 1.34 |
Nov 3, 2023 | 1.57 | 0.18 | 12.95% | 1.39 | 1.68 | 1.39 |
Nanostrg Te Events
Time (UTC) | Country | Event |
---|---|---|
Monday, February 26, 2024 | ||
Time (UTC) 21:00 | Country US
| Event Q4 2023 NanoString Technologies Inc Earnings Release Q4 2023 NanoString Technologies Inc Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 127.262 | 145.085 | 117.316 | 125.568 | 106.732 |
Revenue | 127.262 | 145.085 | 117.316 | 125.568 | 106.732 |
Cost of Revenue, Total | 65.475 | 68.304 | 52.409 | 44.039 | 36.331 |
Gross Profit | 61.787 | 76.781 | 64.907 | 81.529 | 70.401 |
Total Operating Expense | 279.445 | 253.311 | 212.506 | 159.398 | 176.125 |
Selling/General/Admin. Expenses, Total | 143.129 | 115.503 | 90.097 | 96.195 | 78.195 |
Research & Development | 70.841 | 69.504 | 62.857 | 68.035 | 61.599 |
Operating Income | -152.183 | -108.226 | -95.19 | -33.83 | -69.393 |
Interest Income (Expense), Net Non-Operating | -5.126 | -6.841 | -13.664 | -5.668 | -6.1 |
Other, Net | -1.917 | -0.02 | -0.971 | -0.929 | -1.658 |
Net Income Before Taxes | -159.226 | -115.087 | -109.825 | -40.427 | -77.151 |
Net Income After Taxes | -159.543 | -115.254 | -110.078 | -40.696 | -77.4 |
Net Income Before Extra. Items | -159.543 | -115.254 | -110.078 | -40.696 | -77.4 |
Net Income | -159.543 | -115.254 | -110.078 | -40.696 | -77.4 |
Income Available to Common Excl. Extra. Items | -159.543 | -115.254 | -110.078 | -40.696 | -77.4 |
Income Available to Common Incl. Extra. Items | -159.543 | -115.254 | -110.078 | -40.696 | -77.4 |
Diluted Net Income | -159.543 | -115.254 | -110.078 | -40.696 | -77.4 |
Diluted Weighted Average Shares | 46.406 | 45.299 | 39.083 | 34.588 | 27.883 |
Diluted EPS Excluding Extraordinary Items | -3.43798 | -2.54429 | -2.81652 | -1.17659 | -2.77588 |
Diluted Normalized EPS | -3.43798 | -2.54429 | -2.69772 | -2.09501 | -2.77588 |
Total Extraordinary Items | 0 | ||||
Unusual Expense (Income) | 0 | 0 | 7.143 | -48.871 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
Total revenue | 44.157 | 35.805 | 34.422 | 29.541 | 32.219 |
Revenue | 44.157 | 35.805 | 34.422 | 29.541 | 32.219 |
Cost of Revenue, Total | 29.757 | 22.871 | 21.122 | 13.723 | 15.852 |
Gross Profit | 14.4 | 12.934 | 13.3 | 15.818 | 16.367 |
Total Operating Expense | 87.047 | 76.355 | 77.103 | 64.482 | 69.31 |
Selling/General/Admin. Expenses, Total | 39.076 | 37.366 | 36.895 | 33.767 | 36.112 |
Research & Development | 18.214 | 16.118 | 19.086 | 16.992 | 17.346 |
Unusual Expense (Income) | 0 | ||||
Operating Income | -42.89 | -40.55 | -42.681 | -34.941 | -37.091 |
Interest Income (Expense), Net Non-Operating | -0.362 | -0.606 | -0.807 | -1.113 | -1.474 |
Other, Net | -0.211 | -0.007 | -0.631 | -0.579 | -0.49 |
Net Income Before Taxes | -43.463 | -41.163 | -44.119 | -36.633 | -39.055 |
Net Income After Taxes | -43.668 | -41.238 | -44.114 | -36.69 | -39.239 |
Net Income Before Extra. Items | -43.668 | -41.238 | -44.114 | -36.69 | -39.239 |
Net Income | -43.668 | -41.238 | -44.114 | -36.69 | -39.239 |
Income Available to Common Excl. Extra. Items | -43.668 | -41.238 | -44.114 | -36.69 | -39.239 |
Income Available to Common Incl. Extra. Items | -43.668 | -41.238 | -44.114 | -36.69 | -39.239 |
Diluted Net Income | -43.668 | -41.238 | -44.114 | -36.69 | -39.239 |
Diluted Weighted Average Shares | 47.365 | 46.936 | 46.664 | 46.529 | 46.427 |
Diluted EPS Excluding Extraordinary Items | -0.92195 | -0.8786 | -0.94535 | -0.78854 | -0.84518 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | -0.92195 | -0.8786 | -0.94535 | -0.78854 | -0.84518 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 286.774 | 427.62 | 498.98 | 212.607 | 131.707 |
Cash and Short Term Investments | 196.532 | 348.889 | 440.731 | 156.855 | 93.997 |
Cash & Equivalents | 112.25 | 107.068 | 411.848 | 29.033 | 24.356 |
Short Term Investments | 84.282 | 241.821 | 28.883 | 127.822 | 69.641 |
Total Receivables, Net | 31.506 | 40.13 | 31.1 | 27.153 | 17.279 |
Accounts Receivable - Trade, Net | 31.506 | 40.13 | 31.1 | 27.153 | 17.279 |
Total Inventory | 43.273 | 31.486 | 22.959 | 19.781 | 13.173 |
Other Current Assets, Total | 0.898 | ||||
Total Assets | 353.412 | 479.481 | 544.195 | 259.754 | 147.558 |
Property/Plant/Equipment, Total - Net | 62.038 | 46.269 | 42.32 | 44.832 | 15.171 |
Property/Plant/Equipment, Total - Gross | 98.271 | 74.729 | 65.361 | 63.083 | 32.101 |
Accumulated Depreciation, Total | -36.233 | -28.46 | -23.041 | -18.251 | -16.93 |
Other Long Term Assets, Total | 4.6 | 5.592 | 2.895 | 2.315 | 0.68 |
Total Current Liabilities | 58.86 | 52.155 | 37.099 | 44.986 | 43.115 |
Accounts Payable | 16.619 | 14.283 | 5.313 | 10.282 | 8.636 |
Accrued Expenses | 30.896 | 29.12 | 24.545 | 24.318 | 15.765 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | |||||
Other Current Liabilities, Total | 11.345 | 8.752 | 7.241 | 10.386 | 18.714 |
Total Liabilities | 307.598 | 302.519 | 237.247 | 155.603 | 110.689 |
Total Long Term Debt | 226.622 | 225.144 | 172.703 | 79.951 | 58.396 |
Long Term Debt | 226.622 | 225.144 | 172.703 | 79.951 | 58.396 |
Other Liabilities, Total | 22.116 | 25.22 | 27.445 | 30.666 | 9.178 |
Total Equity | 45.814 | 176.962 | 306.948 | 104.151 | 36.869 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock | 0.005 | 0.005 | 0.004 | 0.004 | 0.003 |
Additional Paid-In Capital | 855.694 | 827.028 | 848.891 | 535.954 | 428.162 |
Retained Earnings (Accumulated Deficit) | -809.296 | -649.753 | -542.03 | -431.952 | -391.256 |
Other Equity, Total | -0.589 | -0.318 | 0.083 | 0.145 | -0.04 |
Total Liabilities & Shareholders’ Equity | 353.412 | 479.481 | 544.195 | 259.754 | 147.558 |
Total Common Shares Outstanding | 46.719 | 45.729 | 44.441 | 36.298 | 30.913 |
Prepaid Expenses | 14.565 | 7.115 | 4.19 | 8.818 | 7.258 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
Total Current Assets | 211.807 | 221.445 | 251.858 | 286.774 | 318.708 |
Cash and Short Term Investments | 97.101 | 117.602 | 154.644 | 196.532 | 230.453 |
Cash & Equivalents | 93.802 | 114.305 | 121.408 | 112.25 | 117.069 |
Short Term Investments | 3.299 | 3.297 | 33.236 | 84.282 | 113.384 |
Total Receivables, Net | 48.352 | 42.982 | 34.867 | 31.506 | 27.273 |
Accounts Receivable - Trade, Net | 48.352 | 42.982 | 34.867 | 31.506 | 27.273 |
Total Inventory | 55.159 | 48.849 | 46.711 | 43.273 | 45.761 |
Prepaid Expenses | 10.899 | 11.387 | 15.011 | 14.565 | 15.221 |
Total Assets | 274.713 | 288.99 | 320.415 | 353.412 | 383.6 |
Property/Plant/Equipment, Total - Net | 59.411 | 63.397 | 64.213 | 62.038 | 58.96 |
Other Long Term Assets, Total | 3.495 | 4.148 | 4.344 | 4.6 | 5.932 |
Total Current Liabilities | 77.532 | 62.433 | 57.991 | 58.86 | 50.939 |
Accounts Payable | 33.335 | 20.868 | 20.486 | 16.619 | 16.829 |
Accrued Expenses | 29.696 | 27.199 | 24.118 | 30.896 | 25.013 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 14.501 | 14.366 | 13.387 | 11.345 | 9.097 |
Total Liabilities | 325.279 | 310.451 | 306.795 | 307.598 | 300.672 |
Total Long Term Debt | 227.764 | 227.379 | 227.001 | 226.622 | 226.25 |
Long Term Debt | 227.764 | 227.379 | 227.001 | 226.622 | 226.25 |
Other Liabilities, Total | 19.983 | 20.639 | 21.803 | 22.116 | 23.483 |
Total Equity | -50.566 | -21.461 | 13.62 | 45.814 | 82.928 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 |
Additional Paid-In Capital | 881.038 | 872.732 | 864.204 | 855.694 | 849.406 |
Retained Earnings (Accumulated Deficit) | -931.613 | -894.202 | -850.534 | -809.296 | -765.182 |
Other Equity, Total | 0.004 | 0.004 | -0.055 | -0.589 | -1.301 |
Total Liabilities & Shareholders’ Equity | 274.713 | 288.99 | 320.415 | 353.412 | 383.6 |
Total Common Shares Outstanding | 48.108 | 47.526 | 47.328 | 46.719 | 46.635 |
Other Current Assets, Total | 0.296 | 0.625 | 0.625 | 0.898 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | -159.543 | -115.254 | -110.078 | -40.696 | -77.4 |
Cash From Operating Activities | -128.606 | -90.549 | -81.662 | -89.421 | -54.065 |
Cash From Operating Activities | 8.116 | 5.871 | 5.738 | 4.919 | 4.07 |
Non-Cash Items | 38.05 | 35.332 | 37.227 | -25.438 | 10.372 |
Cash Taxes Paid | 0.18 | 0.189 | 0.357 | 0.265 | 0.231 |
Cash Interest Paid | 6.038 | 6.038 | 4.571 | 5.683 | 6.213 |
Changes in Working Capital | -15.229 | -16.498 | -14.549 | -28.206 | 8.893 |
Cash From Investing Activities | 132.497 | -220.222 | 91.241 | -15.159 | -22.925 |
Capital Expenditures | -23.066 | -8.647 | -7.457 | -7.885 | -4.485 |
Other Investing Cash Flow Items, Total | 155.563 | -211.575 | 98.698 | -7.274 | -18.44 |
Cash From Financing Activities | 2.272 | 6.058 | 373.048 | 109.266 | 75.081 |
Financing Cash Flow Items | -1.504 | -2.585 | -14.26 | -1.574 | -1.716 |
Issuance (Retirement) of Stock, Net | 4.109 | 8.879 | 237.443 | 90.84 | 61.797 |
Issuance (Retirement) of Debt, Net | -0.333 | -0.236 | 149.865 | 20 | 15 |
Foreign Exchange Effects | -0.083 | -0.067 | 0.188 | -0.009 | -0.014 |
Net Change in Cash | 6.08 | -304.78 | 382.815 | 4.677 | -1.923 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -41.238 | -159.543 | -115.429 | -78.739 | -39.5 |
Cash From Operating Activities | -35.749 | -128.606 | -100.525 | -62.723 | -30.253 |
Cash From Operating Activities | 3.536 | 8.116 | 5.151 | 3.504 | 1.543 |
Non-Cash Items | 11.386 | 38.05 | 27.56 | 19.719 | 10.2 |
Changes in Working Capital | -9.433 | -15.229 | -17.807 | -7.207 | -2.496 |
Cash From Investing Activities | 43.798 | 132.497 | 108.384 | 80.671 | 20.705 |
Capital Expenditures | -7.678 | -23.066 | -17.59 | -12.503 | -5.919 |
Other Investing Cash Flow Items, Total | 51.476 | 155.563 | 125.974 | 93.174 | 26.624 |
Cash From Financing Activities | 0.814 | 2.272 | 2.325 | 1.115 | 0.96 |
Financing Cash Flow Items | -0.49 | -1.504 | -1.504 | -1.504 | -1.504 |
Issuance (Retirement) of Stock, Net | 1.374 | 4.109 | 4.086 | 2.802 | 2.537 |
Issuance (Retirement) of Debt, Net | -0.07 | -0.333 | -0.257 | -0.183 | -0.073 |
Foreign Exchange Effects | 0.022 | -0.083 | -0.183 | -0.104 | -0.023 |
Net Change in Cash | 8.885 | 6.08 | 10.001 | 18.959 | -8.611 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 8.362 | 3975756 | 296272 | 2023-06-30 | LOW |
Polar Capital LLP | Investment Advisor/Hedge Fund | 8.3604 | 3975000 | -25000 | 2023-06-30 | LOW |
Prosight Capital | Hedge Fund | 6.6252 | 3150000 | 1150000 | 2023-08-23 | HIGH |
Wygod (Martin J) | Individual Investor | 6.313 | 3001530 | 554748 | 2023-10-04 | MED |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 5.9118 | 2810799 | 270785 | 2023-06-30 | LOW |
Blue Water Life Science Advisors, LLC | Investment Advisor/Hedge Fund | 5.7353 | 2726891 | 2726891 | 2023-06-30 | LOW |
Avidity Partners Management LP | Hedge Fund | 5.6796 | 2700400 | -249600 | 2023-06-30 | HIGH |
D. E. Shaw & Co., L.P. | Hedge Fund | 4.5242 | 2151069 | 236741 | 2023-06-30 | MED |
Titanite Investment Management LP | Investment Advisor | 3.7858 | 1800000 | 1800000 | 2023-08-18 | |
RA Capital Management, LP | Hedge Fund | 3.6247 | 1723373 | -733900 | 2023-06-30 | LOW |
Two Sigma Investments, LP | Hedge Fund | 3.5137 | 1670610 | 428837 | 2023-06-30 | HIGH |
Millennium Management LLC | Hedge Fund | 3.329 | 1582814 | 1302294 | 2023-06-30 | HIGH |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 2.7141 | 1290456 | 161872 | 2023-06-30 | LOW |
Jacobs Levy Equity Management, Inc. | Investment Advisor/Hedge Fund | 2.5475 | 1211232 | 470972 | 2023-06-30 | MED |
Polar Asset Management Partners Inc. | Hedge Fund | 2.3928 | 1137689 | 665700 | 2023-06-30 | HIGH |
Platinum Asset Management | Investment Advisor/Hedge Fund | 2.348 | 1116392 | -113411 | 2023-06-30 | LOW |
Acadian Asset Management LLC | Investment Advisor/Hedge Fund | 2.18 | 1036489 | 739396 | 2023-06-30 | MED |
Cadian Capital Management LP | Hedge Fund | 2.1032 | 1000000 | 1000000 | 2023-06-30 | MED |
Pura Vida Investments, LLC | Hedge Fund | 2.0634 | 981043 | -345907 | 2023-06-30 | HIGH |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.8881 | 897710 | 40819 | 2023-06-30 | LOW |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Nanostrg Te Company profile
About NanoString Technologies Inc
NanoString Technologies, Inc. develops, manufactures, and sells products of biological material. Its core technology includes chemistries that enable the labeling and counting of single molecules. The single-molecule chemistries enable the direct detection, identification, and quantification of individual target molecules in biological samples by attaching molecular reporters to each target molecule of interest. It uses its core technology to develop tools for scientific and clinical research. It offers two product platforms, including nCounter Analysis System, and its GeoMx Digital Spatial Profiler (GeoMx DSP) systems. The nCounter Analysis System is used to analyze the activity of genes in a single experiment and is also used by clinicians to analyze gene activity relevant for diagnostic applications. The GeoMx DSP is used to facilitate the analysis of selected regions of a biological sample to see how gene activity vary across those regions or in certain cell types.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, NanoString Technologies Inc revenues increased 24% to $145.1M. Net loss increased 5% to $115.3M. Revenues reflect Americas segment increase of 18% to $94.4M, Europe & Middle East segment increase of 31% to $35.2M. Higher net loss reflects Selling, general and administrative increase of 22% to $89.4M (expense), Stock-based Compensation in SGA increase of 56% to $21.3M (expense).
Equity composition
Common Stock $0.0001 Par, 06/13, Shares auth 150M, 14,594,745 shares issd, Insiders Own approx. 63%
Industry: | Medical Equipment, Supplies & Distribution (NEC) |
530 Fairview Avenue North
SEATTLE
WASHINGTON 98109
US
Income Statement
- Annual
- Quarterly
News

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
12:39, 30 November 2023
Euro Zone CPI expected to continue dropping; economists warn about cutting too soon
EZ PI expected to drop further but speed of decline
08:16, 29 November 2023
A weaker Dollar drives gold higher
Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.
13:49, 28 November 2023
Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain
US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.
13:20, 28 November 2023
RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023
The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.
13:04, 28 November 2023
Crude prices slide on OPEC+ uncertainty
Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.
12:55, 28 November 2023
UK AUTUMN BUDGET: Will Hunt cut taxes? How will GBP react this time around?
UK Chancellor Hunt will deliver the 2023 autumn statement to MPs on Wednesday 22 November.
10:48, 21 November 2023People also watch
Still looking for a broker you can trust?
Join the 570.000+ traders worldwide that chose to trade with Capital.com